AstraZeneca settles UK tax claim
AFP/The Local - [email protected]
Published: 23 Feb, 2010 CET.
Updated: Tue 23 Feb 2010 15:12 CET
Anglo-Swedish drugmaker AstraZeneca reported on Tuesday that it had reached an agreement with the UK tax authority to pay £505 million ($786 million) to settle a long-standing tax dispute.
The firm said in a statement that by agreeing to resolve claims with the HM Revenue & Customs dating between 1996 and 2010, it was able to upgrade its earnings outlook for 2010.
"AstraZeneca has increased its 2010 target for core earnings per share from $5.75-6.15 to $5.90-6.30 per share," the statement said.
AstraZeneca stock rose by one percent on the London Stock Exchange after announcement.
Comments
See Also
The firm said in a statement that by agreeing to resolve claims with the HM Revenue & Customs dating between 1996 and 2010, it was able to upgrade its earnings outlook for 2010.
"AstraZeneca has increased its 2010 target for core earnings per share from $5.75-6.15 to $5.90-6.30 per share," the statement said.
AstraZeneca stock rose by one percent on the London Stock Exchange after announcement.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.